Vontrader why are you expecting an update from BLT in the next...

Vontrader why are you expecting an update from BLT in the next few days?

The company is trying to find suitable candidates to test it's TT-034 HCV drug. But problem is that first up it will test a sub-therapeutic dose. Once TT-034 is administered it cannot be readministered later, which means the first few people tested wont be cured and can't be given a therapeutic does later on. The company is already 2 months behind it's own timeline.